Pepper Bio
The world's first transomics company
Boston, United States · $6.5M raised
- Headquarters
- Boston
- Employees
- 1–10
- Business Model
- B2B
- Website
- pepper.bio
- Total Funding
- $6.5M
- Last Round
- $6.5M SeedNov 2023
- Rounds
- 1
About
Pepper Bio is a Boston-based biotech startup and self-described "world's first transomics company," combining DNA, RNA, proteomic, and phosphoproteomic data to identify better drug targets and improve drug-discovery success rates. Led by CEO Jon Hu and CSO Samantha Dale Strasser, the company partners with pharmaceutical firms including Merck via Merck Digital Sciences Studio, runs its own internal oncology pipeline, and collaborates with Stanford's Felsher Lab on lymphatic and liver cancer targets.
Summary
Pepper Bio is a Biotech company based in Boston, United States. It has raised $6.5M in total across 1 round, most recently a $6.5M Seed round in Nov 2023. Investors include NFX.
Funding History
Nov 2023
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pepper-bio"><img src="https://indexed.vc/api/badge/company/pepper-bio" alt="Pepper Bio on Indexed.vc" width="260" height="76" /></a>